cover image - Clinical Manifestations and Assessment of Respiratory Disease Elsevier eBook on VitalSource, 8th Edition
ISBN: 9780323571012
Copyright: 2020
Publication Date: 03-06-2019
Page Count: 673
Imprint: Mosby
List Price: $118.99

Clinical Manifestations and Assessment of Respiratory Disease Elsevier eBook on VitalSource, 8th Edition

by Terry Des Jardins, MEd, RRT and George G. Burton, MD, FACP, FCCP, FAARC

Elsevier eBook on VitalSource

cover image - Clinical Manifestations and Assessment of Respiratory Disease Elsevier eBook on VitalSource, 8th Edition
ISBN: 9780323571012
Copyright: 2020
Publication Date: 03-06-2019
Page Count: 673
Imprint: Mosby
List Price: $118.99
Was $118.99

Now $104.71

Or $0.00 with a valid access code

A realistic look at treating respiratory diseases! Clinical Manifestations and Assessment of Respiratory Disease, 8th Edition gives you a fundamental knowledge and understanding that is required to successfully assess and treat patients with respiratory diseases. Using a unique organization of material, this full-color text is divided into three distinct areas which show you how to first gather clinical data, then formulate assessments, make objective evaluations, identify desired outcomes, design a safe and effective treatment plan, and finally document all steps. With easy-to-follow language and relevant clinical scenarios, you will gain a firm understanding of why certain treatment modalities are applied. New to this edition is a chapter detailing Respiratory Insufficiency in the Patient with Neuro-Respiratory Disease, along with revised content which takes a deeper dive into latest developments, research, and practices and protocols in the treatment of respiratory disease.

New Edition Expected Availability: 04-19-2023

Clinical Manifestations and Assessment of Respiratory Disease - Elsevier eBook on VitalSource, 9th Edition
9th Edition

Clinical Manifestations and Assessment of Respiratory Disease - Elsevier eBook on VitalSource

Elsevier eBook on VitalSource
ISBN: 9780323871525
    • NEW! Respiratory Insufficiency in the Patient with Neuro-Respiratory Disease chapter outlines the respiratory therapist’s role in regard to these protocols.
    • NEW! Illustrations in designated chapters ensures you have a visual representation of disease processes, and the latest assessment and treatment procedures.
    • Revised content in the disease sections reflect the latest developments, research, and practices and protocols in the treatment of respiratory disease
    • UPDATED! Case studies on Evolve provide realistic examples of the respiratory therapist’s role in successful patient care and help you apply text information to clinical assessment and treatment
    • UNIQUE! Emphasis on clinical scenarios and critical thinking skills helps students understand the causes of the clinical manifestations activated by specific respiratory disorders
    • UNIQUE! Focus on assessment and Therapist-Driven Protocols (TDPs) emphasizes industry-approved standards of care, providing you with the knowledge and skills to implement these protocols into patient care
    • Overview boxes summarize the clinical manifestations caused by the pathophysiologic mechanisms of each disorder
    • Self-assessment questions at the end of the text help you to personally assess your understanding of chapter material
    • Student-friendly features reinforce learning with chapter outlines, objectives, key terms, and easy-to-follow language

  • PART 1: Assessment of Cardiopulmonary Disease
    SECTION I: Bedside Diagnosis
    1. The Patient Interview
    2. The Physical Examination
    3. The Pathophysiologic Basis for Common Clinical Manifestations

    SECTION II: CLINICAL DATA OBTAINED FROM LABORATORY TESTS AND SPECIAL PROCEDURES—Objective Findings
    4. Pulmonary Function Testing
    5. Blood Gas Assessment
    6. Assessment of Oxygenation
    7. Assessment of the Cardiovascular System
    8. Radiologic Examination of the Chest
    9. Other Important Tests and Procedures

    SECTION III: THE THERAPIST-DRIVEN PROTOCOL PROGRAM—THE ESSENTIALS
    10. The Therapist-Driven Protocol Program
    11. Respiratory Insufficiency, Respiratory Failure and Ventilatory Management Protocols
    12. Recording Skills and Intra-Professional Communication

    PART II: Obstructive Lung Disease
    13. Chronic Obstructive Pulmonary Disease, Chronic Bronchitis and Emphysema
    14. Asthma
    15. Cystic Fibrosis
    16. Bronchiectasis

    PART III: Loss of Alveolar Volume
    17. Atelectasis

    PART IV: Infectious Pulmonary Disease
    18. Pneumonia, Lung Abscess Formation and Important Fungal Diseases
    19. Tuberculosis

    PART V: Pulmonary Vascular Disease
    20. Pulmonary Edema
    21. Pulmonary Vascular Disease: Pulmonary Embolism and Pulmonary Hypertension

    PART VI: Chest and Pleural Trauma
    22. Flail Chest
    23. Pneumothorax

    PART VII: Disorders of the Pleura and of the Chest Wall
    24. Pleural Effusion and Empyema
    25. Kyphoscoliosis

    PART VIII: Lung Cancer
    26. Cancer of the Lung: Prevention and Palliation

    PART IX: Environmental Lung Diseases
    27. Interstitial Lung Diseases

    PART X: Diffuse Alveolar Disease
    28. Acute Respiratory Distress Syndrome

    PART XI: Neuro-Respiratory Disorders
    29. Guillain-Barre Syndrome
    30. Myasthenia Gravis
    31. Respiratory Insufficiency in the Patient with Neuro-Respiratory Disease

    PART XII: Sleep-Related Breathing Disorders
    32. Sleep Apnea

    PART XIII: Newborn and Early Childhood Cardiopulmonary Disorders
    33. The Newborn Disorders
    34. Pediatric Assessment, Protocols, and PALS Management
    35. Meconium Aspiration Syndrome
    36. Transient Tachypnea of the Newborn
    37. Respiratory Distress Syndrome
    38. Pulmonary Air Leak Syndrome
    39. Respiratory Syncytial Virus Infection (Bronchiolitis)
    40. Chronic Lung Disease of Infancy
    41. Congenital Diaphragmatic Hernia
    42. Congenital Heart Disease
    43. Croup and Croup-like Syndromes: Laryngotracheobronchitis, Bacterial Tracheitis and Acute Epiglottitis

    PART XIV: Other Important Topics
    44. Near Drowning/Wet Drowning
    45. Smoke Inhalation, Thermal Injuries, and Carbon Monoxide IntoxicationTentative (based on current edition)

    Appendix
    1. Symbols and Abbreviations Commonly Used in Respiratory Physiology
    2. Agents Used to Treat Bronchospasm and Airway Inflammation
    3. Antibiotics
    4. Antifungal Agents
    5. Mucolytic and Expectorant Agents
    6. Positive Inotropes and Vasopressors
    7. Diuretic Agents
    8. The Ideal Alveolar Gas Equation
    9. Physiologic Dead Space Calculation
    10. Units of Measure
    11. Poiseuille’s Law
    12. PCO2/HCO3_/pH Nomogram
    13. Calculated Hemodynamic Measurements
    14. DuBois Body Surface Area Chart
    15. Cardiopulmonary Profile
    16. Answers to Self-Assessment Questions

  • Terry Des Jardins, MEd, RRT, Director, Professor Emeritus, Department of Respiratory Care, Parkland College, Champaign, Illinois, USA and George G. Burton, MD, FACP, FCCP, FAARC, Associate Dean for Medical Affairs, Kettering College of Medical Arts, Kettering, Ohio; Clinical Professor of Medicine and Anesthesiology, Wright State University School of Medicine, Dayton, Ohio, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
      • Has alternative text descriptions for images
    • Conformance
    • Navigation
      • Table of contents to all chapters of the text via links
      • Index with links to referenced entries
      • Page list to go to pages from the print source version
    • Rich Content
      • Math formulas in accessible format (MathML)
      • Chemical formulas in accessible format (MathML)
      • Information-rich images are described by extended descriptions
    • Hazards
      • The publication contains no hazards
    • Product Content
      • Content includes any type of illustrations.
      • The primary content is text.
      • Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
      • Content includes a significant number of actionable (clickable) cross-references, hyperlinked notes and annotations, or with other actionable links between largely textual elements (e.g., quiz/test questions, 'choose your own ending', etc.).
      • Content includes photographs, whether in a plate section / insert or not.
      • Content includes figures, diagrams, charts and/or graphs, including other 'mechanical' (i.e. non-photographic) illustrations.
      • Content includes narrative animation, e.g., cartoon, animatic or CGI animation (usually includes sound).
      • Content includes a significant number of web links (printed URLs, QR codes etc.).
      • Content includes images displayed in a specific order for the purpose of graphic storytelling or giving information (e.g. graphic novels, comics and manga). May include text integrated into the image (as speech and thought bubbles, textual 'sound' effects, captions etc.).
      • Content includes chemical notations, formulae.
      • Content includes mathematical notations, formulae.
      • At least some text - including text within other images - is 'text as an image' (i.e., a picture of text).
      • Product includes actionable (clickable) links to external interactive content.
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Content provides explanations for unusual words, abbreviations, acronyms, idioms, jargon in an accessible form, such as glossaries, scripted pop-ups.
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $118.99

Now $104.71

Or $0.00 with a valid access code